Adapting Oncology Pharmacy to the Age of AI and Drug Shortages
Oncology pharmacists are increasingly shaping patient care.
FDA Approves Tonmya, First Treatment for Fibromyalgia in Over 15 Years
FDA approves Tonmya, the first new fibromyalgia treatment in 15 years, offering hope for effective pain relief and improved quality…
1053: The Sicker the Patient, the Worse Dexmedetomidine Performs?
Show notes at pharmacyjoe.com/episode1053. In this episode, I’ll discuss predicting the chance of successful sedation and the development of hypotension…
Selection Considerations for Abemaciclib Versus Ribociclib in Early HR+/HER2- Breast Cancer: Efficacy, Safety, and Long-Term Outcomes
New research highlights abemaciclib and ribociclib as promising treatments for early HR-positive, HER2-negative breast cancer, emphasizing survival benefits and side…
Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in Unresectable HCC
Combination therapy with tremelimumab and durvalumab significantly improves survival in liver cancer patients compared to standard sorafenib treatment.
Trastuzumab and HER2-Targeted Therapy: Breaking Down the Basics
Morgan Cantley, PharmD, BCOP, shares key insights about the HER2-targeting antibody drug conjugate trastuzumab deruxtecan.
Study Finds Widespread Gaps in Knowledge About HPV and Its Link to Cancer
Many adults remain unaware of HPV’s cancer risks, highlighting the urgent need for increased awareness.
A Pharmacist’s Guide to New IDSA Guidelines for Complicated UTIs
IDSA updated cUTI guidelines for men and women emphasize antibiotic selection, transition to oral therapy, and optimal treatment duration.
New Clinical Data Highlight Revumenib’s Potential Beyond KMT2A-Rearranged Leukemia
Revumenib shows promise in treating NPM1-mutant AML, expanding its role in precision oncology and offering hope for targeted leukemia therapies.
Novel Prescription Digital Therapeutic Improves Negative Symptoms of Schizophrenia
CT-155, an investigational prescription digital therapeutic, was found to improve motivation, sociality, and other negative symptoms in patients with schizophrenia…